The groundbreaking treatment of tirzepatide peptide represents a major development in the handling of the condition. Unlike existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide106468.prublogger.com/40827408/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment